Benchmark Narrative Against Venture DNA Criteria
Evaluate the synthesised narrative against internal venture DNA, market positioning, historical performance data, and external investor expectations for this specific funding stage. Stress-test whether the growth trajectory claimed matches actual historical execution capability and unit economics.
Testing the aligned narrative against venture reality verifies that claims are grounded in validated performance rather than unbacked optimism. This protects valuation credibility and ensures the pitch stands up to rigorous institutional due diligence.
The founder must produce a comparative evaluation table comparing pitch narrative claims against verified historical venture DNA metrics. This must explicitly highlight where strategic claims rely on proven empirical data versus unvalidated forward-looking assumptions.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What historical performance metrics prove that your team can execute on the accelerated growth trajectory proposed in the narrative?
- 2
How well does your valuation expectation align with current UK seed and Series A benchmark multiples for your sector?
- 3
In what ways does your use of funds directly address the core technical and commercial risks identified in your venture DNA?
- 4
Why should an investor believe your customer acquisition cost will decrease as you scale into larger markets?
- 5
How does your narrative justify the proposed post-money valuation given your current monthly recurring revenue and churn rate?